Discontinuing antiresorptive therapy one year after cardiac transplantation: Effect on bone density and bone turnover

Transplantation

Volumn 81, Issue 5, 2006, Pages 686-691

  Cohen, Adi ^a   Addesso, Vicki ^a   McMahon, Donald J ^a   Staron, Ronald B ^a   Namerow, Pearila ^b   Maybaum, Simon ^a   Mancini, Donna ^a   Shane, Elizabeth ^a  

^a Columbia University ^*  (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Active vitamin D metabolites; Bisphosphonates; Bone loss; Bone turnover; Fracture; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CALCITRIOL;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTURE; HALF LIFE TIME; HEART TRANSPLANTATION; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECIPIENT;

ADULT; ALENDRONATE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; CALCITRIOL; COLLAGEN; COLLAGEN TYPE I; FEMALE; FRACTURES, BONE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIDES; SPINAL INJURIES;

EID: 33645076285     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000177645.63999.ca     Document Type: Article

References (22)

1. Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003; 14: 617.
2. Sambrook PN, Kelly PJ, Keogh AM, et al. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 1994; 13: 116.
3. Berguer DG, Krieg MA, Thiebaud D, et al. Osteoporosis in heart transplant recipients: a longitudinal study. Transplant Proc 1994; 26: 2649.
4. Van Cleemput J, Daenen W, Nijs J, et al. Timing and quantification of bone loss in cardiac transplant recipients. Transpl Int 1995; 8: 196.
5. Thiebaud D, Krieg MA, Gillard-Berguer D, et al. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26: 549.
6. Shane E, Rivas M, McMahon DJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 1997; 82: 1497.
7. Shane E, Addesso V, Namerow PB, et al. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 2004; 350: 767.
8. Shane E, Rivas M, Staron RB, et al. Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 1996; 81: 1740.
9. Leidig-Bruckner G, Hosch S, Dodidou P, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001; 357: 342.
10. Cohen A, Sambrook P, Shane E. Management of bone loss after organ transplantation. J Bone Miner Res 2004; 19: 1919.
11. Sambrook P, Henderson NK, Keogh A, et al. Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 2000; 15: 1818.
12. Bianda T, Linka A, Junga G, et al. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 2000; 67: 116.
13. Hommann MK, Abendroth G, Lehmann N, et al. Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation. Transplant Proc 2002; 34: 2296.
14. Aris RM, Lester GE, Renner JB, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000; 162: 941.
15. Fan SL, Almond MK, Ball E, et al. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000; 57: 684.
16. Coco M, Glicklich D, Faugere MC, et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003; 14: 2669.
17. Black D, Palermo L, Nevitt M, et al. Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures J Bone Miner Res 1995; 10: 890.
18. Wu C, Li J, Jergas M, Genant H. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporosis Int 1995; 5: 354.
19. Genant H, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996; 11: 984.
20. Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249.
21. Henderson K, Eisman J, Keogh A, et al. Protective effect of short-tern calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 2001; 16: 565.
22. Fan SL, Kumar S, Cunningham J. Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation. Kidney Int 2003; 63: 2275.